Search clinical trials for: Tacrolimus

Total 1101 results

Astellas Pharma Inc

Completed

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis

Dermatitis, Atopic

United States
Astellas Pharma Inc

Completed

Protopic Ointment in Adult Atopic Eczema of the Face

Dermatitis, Atopic

France
University of Minnesota
Wyeth is now a wholly owned subsidiary of Pfizer; Roche Pharma AG; Genzyme, a...

Completed

Calcineurin Inhibitor Sparing After Kidney Transplantation (CNI-Sparing)

CNI Side Effects

United States
Astellas Pharma China, Inc.

Completed

A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis

Lupus Nephritis

China
University of Maryland, Baltimore

Completed

Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients

Bronchiolitis Obliterans | Chronic Rejection of Lung Transplant | Disorder Related to Lung Transplantation | Decreased Immunologic Activity

United States
Shin Mineishi
Milton S. Hershey Medical Center

Withdrawn

Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and Leukemia

Lymphoma | Leukemia
Astellas Pharma Inc

Completed

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus. (ADHERE)

Kidney Transplantation

Australia, Austria, Belarus, Belgium, Czechia, France, Germany, Hong Kong, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Taiwan, Turkey
Chong Kun Dang Pharmaceutical

Completed

Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis (TIARA)

Rheumatoid Arthritis

Korea, Republic of
Astellas Pharma Inc

Completed

A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis

Dermatitis, Atopic

United States, Canada
Hoffmann-La Roche

Completed

Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.

Kidney Transplantation

United States
The Second Hospital of Tangshan
Chinese PLA General Hospital

Recruiting

Investigation of Pain Incidence After FK506 Immunosuppressive Therapy in Liver Transplantation Patients

Liver Transplantation | Chronic Pain

China
University of Manitoba

Completed

Comparative FK506 Drug Levels of Once Daily Advagraf in First Nations and Caucasian Patients With Liver Transplants

Liver Failure

Canada
The Eye Center and The Eye Foundation for Research...

Unknown

Ocular Penetration of Topical Tacrolimus Eye Drops

Ocular Penetration of Topical Tacrolimus

Saudi Arabia
Veloxis Pharmaceuticals

Approved for marketing

Expanded Access Study for Renal Transplant Patients With Envarsus XR ™

Renal Failure
Helio Tedesco Silva Junior
Sanofi; Novartis

Completed

Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria

Kidney Transplantation | Cytomegalovirus

Brazil
Astellas Pharma Inc

Completed

A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation

Kidney Transplantation

China
Sanofi

Recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor (AQUA)

Dermatitis Atopic

Argentina, Chile, Germany, Japan, Spain, United Kingdom, Canada, United States, Brazil, France, Turkey, Israel, Korea, Republic of, China
NYU Langone Health
Bristol-Myers Squibb

Recruiting

Belatacept in De Novo Heart Transplantation

Heart Transplantation

United States
Second Affiliated Hospital, School of Medicine,...

Enrolling by invitation

3T Therapy in the Treatment of MDA5-positive Dermatomyositis

Dermatomyositis

China
H. Lee Moffitt Cancer Center and Research Institute
Gateway for Cancer Research

Completed

Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease (Ustekinumab)

Graft vs. Host Disease

United States
National Cancer Institute (NCI)

Terminated

Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders

Leukemia | Multiple Myeloma | MDS | Non-Hodgkins Lymphoma | Hodgkins Lymphoma

United States
Ramathibodi Hospital
Rajavithi Hospital; King Chulalongkorn Memorial Hospital; Srinagarind Hospital... and other collaborators

Completed

Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis

Lupus Nephritis

Thailand
Astellas Pharma Inc

Completed

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis

Dermatitis, Atopic

United States
Astellas Pharma Inc

Completed

Protopic Ointment in Children Atopic Eczema

Dermatitis, Atopic

France
Zhi-Hong Liu, M.D.
The First Affiliated Hospital with Nanjing Medical University; China Medical... and other collaborators

Completed

Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis

Lupus Nephritis

China
Université de Sherbrooke
McMaster University

Recruiting

Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY) (CINERGY)

Ischemic Reperfusion Injury | Brain Death | Organ Transplant Failure or Rejection

Canada
Roberto Gedaly
Veloxis Pharmaceuticals

Recruiting

Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

End Stage Renal Disease

United States
Barts & The London NHS Trust

Withdrawn

ENvarsus for Impaired Glucose Tolerance Post REnal transplAnT (ENTREAT)

Renal Transplant Failure

United Kingdom
University of Kansas Medical Center
Veloxis Pharmaceuticals

Completed

Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Immediate Release Tacrolimus to Slow Release Envarsus

End Stage Renal Disease

United States
Astellas Pharma Europe Ltd.

Completed

A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant (ADDRESS)

Liver Transplant | Kidney Transplant

Italy, Spain, Belgium, Germany, Latvia, Canada, Korea, Republic of, Czechia, Austria, Finland, Belarus, Estonia, France, Hungary, Ireland, Netherlands, Poland, Portugal, Romania, Russian Federation, Slovakia, Sweden, Switzerland, United...
Tang-Du Hospital

Recruiting

TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study (TREAT-OMG)

Ocular Myasthenia Gravis

China
Hospital Universitario 12 de Octubre
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz; Fundación... and other collaborators

Completed

Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy (STARMEN)

MEMBRANOUS NEPHROPATHY

Spain
Weill Medical College of Cornell University

Completed

Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation

Kidney Failure, Chronic

United States
University of North Carolina, Chapel Hill

Completed

Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients (TAC3A5)

Renal Transplant

United States
University of Colorado, Denver

Completed

CNS Study of Patients Switching From Tacrolimus to Envarsus

Renal Transplant Patients

United States
Weill Medical College of Cornell University

Terminated

Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status (TIMELY)

Immunosuppression

United States
Astellas Pharma Inc

Completed

A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients

Transplantation

Netherlands, Spain, Germany, United Kingdom, Poland, France
Eledon Pharmaceuticals

Recruiting

Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

Kidney Transplant Rejection

United States, Spain, Australia, Germany, Canada, France, Brazil
University of Michigan Rogel Cancer Center

Completed

Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies

Hematologic Malignancies | Graft-Versus-Host Disease | Relapse

United States
Seoul National University Hospital

Unknown

Influence of CYP3A5 Polymorphism on Liver Function Abnormality and the Trough Level Change After Conversion

Liver Dysfunction

Korea, Republic of
Astellas Pharma Europe Ltd.

Terminated

To Validate an Analytical Method to Measure Concentration of Tacrolimus in Blood Taken From Finger Pricks

Validation | Dried Blood Spot | Transplant Patients

France, United Kingdom
Centre Hospitalier Universitaire de Nice

Terminated

Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control

Pigmentation Disorders | Vitiligo

France
Astellas Pharma Inc
Astellas Pharma Korea, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients

IgA Nephropathy

Korea, Republic of
Astellas Pharma Inc

Completed

A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy

Erectile Dysfunction | Prostate Cancer

United States
University Hospital, Essen

Recruiting

Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney Transplantation (Pro-Tac)

Pediatric Kidney Disease

Germany
Imperial College London

Recruiting

Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation (EVITRA)

Immunosuppression | Kidney Transplant Failure | Allosensitization

United Kingdom
Medical University of Warsaw

Recruiting

Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial

Immunosuppression | Liver Transplant Rejection

Poland
Chang Gung Memorial Hospital
Astellas Pharma Taiwan, Inc.

Recruiting

A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant

Liver Transplantation

Taiwan
Pusan National University Hospital

Completed

Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis

Seborrheic Dermatitis

Korea, Republic of
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma

Asthma, Bronchial | Bronchial Asthma

Russian Federation, Poland, Germany, Ukraine, Czech Republic

Search clinical trials for: Tacrolimus

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations